A comparison of seven automotive requirements management platforms for 2026, evaluating Jama Connect, Visure, Codebeamer, Polarion, IBM DOORS, Valispace, and ReqView across ISO 26262 compliance, ...

Microsoft packed Copilot with AI upgrades across apps in June, including smarter workflows and features you may like.

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing ...

Dynamic arrays have brought significant flexibility to Excel, allowing formulas to automatically expand or contract across cells. However, this functionality introduces a common issue: formatting ...

A federal judge has declined to temporarily block President Trump's executive order that calls for restricting voting by mail. The ruling released on May 28 by U.S. District Judge Carl Nichols, a ...

Before installing, confirm you meet the following requirements. Subscription Requirements: A Claude Pro, Max, Team, or Enterprise plan. Supported Excel Versions ...

Microsoft is working to address a known issue that renders the Classic Outlook email client unusable for users who have enabled the Microsoft Teams Meeting Add-in. "Some users may be unable to use ...

The AgreeTo add-in for Outlook has been hijacked and turned into a phishing kit that stole more than 4,000 Microsoft account credentials. Originally a legitimate meeting scheduling tool for Outlook ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eikon Therapeutics increased the ...

Eikon Therapeutics shares were down 6%, at $16.90, in the stock's first day of trade on the Nasdaq Global Select Market. Shares of the clinical-stage biopharmaceutical company began trading midday ...

Feb ‌5 (Reuters) - Drug developer Eikon Therapeutics, headed ‌by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares opened 5.3% below their offer price in their Nasdaq ...